Share

Sami Samir Amr

Ph.D.

Associate Director, MGB Laboratory of Molecular Medicine

Director, Translational Genomics Core, MGB Personalized Medicine

Assistant Professor of Pathology Harvard Medical School

Dr. Sami S Amr is an Assistant Professor in the Department of Pathology at Brigham and Women’s Hospital and Harvard Medical School. He is also Associate Director of the Laboratory of Molecular Medicine and Director of the Biobank Genomics Core at Mass General Brigham Personalized Medicine. Dr. Amr is also board certified in clinical molecular genetics by the American Board of Medical Genetics and Genomics (ABMGG).

Dr. Amr’s career spans over 10 years in clinical molecular diagnostics, where he has led the development and implementation of several clinical assays including large gene panels for inherited disease as well as smaller panels/assays for technically challenging regions or genes. In addition, has been involved in analysis, interpretation and reporting of clinical genetics testing for a variety of genetic disease areas with a focus on hearing loss. Dr. Amr serves as co-chair of the ClinGen Hearing Loss Working Group whose efforts focus on the standardization of variant classification and the assessment of gene-disease association in this disease area. He has also been involved in national committees to assess genetic screening as part of newborn hearing screen testing and on several clinical translational projects involving hearing loss testing.

Dr. Amr has authored or co-authored over 40 publications on clinical and technical aspects of genetic testing, molecular diagnostics, and approaches to genetic data interpretation. He has also lectured on a broad range of topics in the clinical diagnostics and biomarkers discoveries at national and international conferences. In addition, Dr. Amr plays an active role in the mentorship and training of clinical and laboratory AMBGG fellows as well genetic counselors, medical students, and colleagues

Sami Samir Amr

Ph.D.

Associate Director, MGB Laboratory of Molecular Medicine

Director, Translational Genomics Core, MGB Personalized Medicine

Assistant Professor of Pathology Harvard Medical School

Dr. Sami S Amr is an Assistant Professor in the Department of Pathology at Brigham and Women’s Hospital and Harvard Medical School. He is also Associate Director of the Laboratory of Molecular Medicine and Director of the Biobank Genomics Core at Mass General Brigham Personalized Medicine. Dr. Amr is also board certified in clinical molecular genetics by the American Board of Medical Genetics and Genomics (ABMGG).

Dr. Amr’s career spans over 10 years in clinical molecular diagnostics, where he has led the development and implementation of several clinical assays including large gene panels for inherited disease as well as smaller panels/assays for technically challenging regions or genes. In addition, has been involved in analysis, interpretation and reporting of clinical genetics testing for a variety of genetic disease areas with a focus on hearing loss. Dr. Amr serves as co-chair of the ClinGen Hearing Loss Working Group whose efforts focus on the standardization of variant classification and the assessment of gene-disease association in this disease area. He has also been involved in national committees to assess genetic screening as part of newborn hearing screen testing and on several clinical translational projects involving hearing loss testing.

Dr. Amr has authored or co-authored over 40 publications on clinical and technical aspects of genetic testing, molecular diagnostics, and approaches to genetic data interpretation. He has also lectured on a broad range of topics in the clinical diagnostics and biomarkers discoveries at national and international conferences. In addition, Dr. Amr plays an active role in the mentorship and training of clinical and laboratory AMBGG fellows as well genetic counselors, medical students, and colleagues

Recent Publications

Characterization of a possible founder synonymous variant in TECTA in multiple individuals with autosomal recessive hearing loss

Published On 2022 Jul 23

Journal article

Synonymous variants have been shown to alter the correct splicing of pre-mRNAs and generate disease-causing transcripts. These variants are not an uncommon etiology of genetic disease; however, they are frequently overlooked during genetic testing in the absence of functional and clinical data. Here, we describe the occurrence of a synonymous variant [NM_005422.4 (TECTA):c.327C>T, p.(Gly109=)] in seven individuals with hearing loss from six unrelated families. The variant is not located near...


Automated Pharmacogenomic Reports for Clinical Genome Sequencing

Published On 2022 Jan 18

Journal article

Clinical laboratories offering genome sequencing have the opportunity to return pharmacogenomic findings to patients, providing the added benefit of preemptive testing that could help inform medication selection or dosing throughout the lifespan. Implementation of pharmacogenomic reporting must address several challenges, including inherent limitations in short-read genome sequencing methods, gene and variant selection, standardization of genotype and phenotype nomenclature, and choice of...